Preemptive versus prophylactic approaches in the management of cytomegalovirus disease in solid organ transplant recipients: what we know and what we do not know

Clin Infect Dis. 2006 Oct 1;43(7):881-3. doi: 10.1086/507338. Epub 2006 Aug 23.
No abstract available

Publication types

  • Comment
  • Editorial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antiviral Agents / therapeutic use*
  • Cytomegalovirus
  • Cytomegalovirus Infections / prevention & control*
  • Ganciclovir / therapeutic use*
  • Humans
  • Opportunistic Infections / prevention & control
  • Organ Transplantation / adverse effects*
  • Preventive Medicine
  • Transplantation

Substances

  • Antiviral Agents
  • Ganciclovir